MBGPF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Moberg Pharma AB (publ)

Watchlist Manager

Watchlist

Price: 1.1 USD

Market Cap: $53.6m

	Moberg Pharma AB (publ) OTC:MBGPF	SE
M	Magnis Energy Technologies Ltd XMUN:U1P	AU
O	OsstemImplant Co Ltd KOSDAQ:048260	KR

Profitability Summary

Moberg Pharma AB (publ)'s profitability score is 22/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

57%

Strong 3Y Average Gross Margin

66%

Declining Gross Margin

100% > 57%

Negative Operating Margin

-207%

Negative 3Y Average Operating Margin

-2.570%

Operating Margin is Increasing

-10.546% > -207%

Negative Net Margin

-201%

Negative 3Y Average Net Margin

-2.239%

Net Margin is Increasing

-7.848% > -201%

Negative Free Cash Flow Margin

-129%

Negative 3Y Average Free Cash Flow Margin

-1.766%

Free Cash Flow Margin is Increasing

-10.437% > -129%

Negative ROE

-4%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-17%

Declining ROIC

-4% > -7%

View All

Hide

Collapse

22 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.